1177 AVENUE OF THE AMERICAS, NEW YORK, NY
Director Retirement - Dr. Andrew Keller Will Not Seek Reelection
Other Events
Sunshine Biopharma Enters $4M At-The-Market Sales Agreement with Aegis Capital
Sunshine Biopharma Enters $1.5 Million Settlement with Former Subsidiary Pres...
Shareholder Approval for Issuance of Common Stock at Discount
Announces Closing of up to $18.0 Million Public Offering
Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year
Engages Aegis Capital Corp. for Warrant Solicitation Transaction
Q2
Q1
FY 2025
Notice of Late Filing for Annual Report
Q3
FY 2024
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
S-1
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(4)
Definitive Information Statement
Preliminary Information Statement
Definitive Proxy Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload
Post-Effective Amendment to Registration Statement